KNOWLEDGE MANAGEMENT CASE STUDIES AND 

TECHNOLOGIES

1. Background and motivation:


The evolution of Aspen Pharma care Holdings Limited from its origins less than 20years ago is a success story worthy of analysis. Aspen began trading in 1997 as as small pharmaceutical business managed out of a suburban house in Durban,South Africa and by 2004 had achieved revenues of R2,2 billion. Aspen has now grown to become a global company with offices in approximately 50 locations across the world and revenues of R29,5 billion in 2014. Given the rapid and sustained growth achieved by Aspen over the past 11 years (2004 – 2014), the main aim of this study was to identify and analyses the growth strategies adopted by Aspen over this time period. 

2.Strategic objectives:

The main purpose of this study was to identify and analyses the growth strategies
adopted by Aspen during the period from 2004 to 2014.
Businesses and their leaders are faced with a paradoxical challenge. On the one
hand creating value, realizing profits and achieving growth are all important
elements in ensuring the survival and success of a business. On the other hand
these endeavors also pose some of the greatest challenges to chief executives
and their management team

3.Development of knowledge management:


Aspen is a supplier of branded and generic pharmaceutical products globally as well as infant nutritional and consumer healthcare products in selected territories (Aspen, 2014).
The company was established in a suburban home in Durban,
South Africa in 1997. A year later it listed on the Johannesburg Stock Exchange 2 (“JSE”) (the South African stock exchange) through a reverse listing into Med hold Limited (Aspen, 2014). The following year Aspen acquired South African Druggists, the largest South African-owned pharmaceutical company at the time (Cairns, 2011), for R2,4 billion in a highly leveraged hostile takeover described as
a mouse eating an elephant (Calabash, 2014).


4.Process and milestones: 


Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes per-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigation new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.


5. Knowledge management Application:  


A common industry definition (Wikipedia) defines knowledge management (KM) as “… the process of capturing, developing, sharing, and effectively using organizational knowledge. It refers to a multi-disciplined approach to achieving organizational objectives by making the best use of knowledge.” Ever since the International Conference on Harmonization (WWW.ich.org) identified, in their Q10 quality guideline (June 2008), both knowledge management and risk management as key-enablers and key tenets of a pharmaceutical quality system, industry has been exploring mechanisms and principles for their implementation ever since.
Zenith Technologies was one of the many attendees at the recent and prestigious ‘Knowledge Management’ conference held in the impressive surroundings of Dublin Castle. The two-day event held on Thursday the 26th and Friday 27th March 2015 incorporated five keynote sessions, three industry insights, three breakout and moderated feedback sessions, multiple interactive panel discussions, one research session, and many networking opportunities over lunch and dinner gatherings. Regulatory Science Ireland, in conjunction with the Dublin Institute of Technology (DIT) and the Health Products Regulatory Authority (HPRA) in Ireland, ought to be highly commended and praised for an educational, informative, and well-organized and attended event. Zenith Technologies was honored to sponsor the lanyards worn by all delegates at the conference.

6.Technology architecture and Infrastructure:

technology framework for demand management within a dad on the supply chain pharmaceutical industry. The paper adopts the exploratory study as research method, involving a producer of generic drugs and its main distributor. Data was collected by semi-structured interviews. In pharmaceutical supply chain, sharing information boosted by information technology translates into greater flexibility and reliability, lower costs, obtained through more reliable forecasting, and lower inventory requirements. There are few initiatives involving Information Technology (IT) applied to demand management in pharmaceutical supply chains available in the literature. It was found that the IT framework proposed in this research is adherent to the demand management of the focused pharmaceutical dyed. Other assumption was that, if partners processes integration exist, better supply chain performance is achieved. It was found that, by means of proposed tools and solutions, such as RF ID and involved partners applications integration, this goal could be achieved. Because of the chosen research approach, results may be restricted to these specific dyadic processes. Further application of the proposed IT framework must be tested. The paper identifies demand management strategic and operational processes that can reach a better performance by using the proposed IT framework. Based on the literature, were identified which IT requirements should be met to demand management processes optimization.


7.incentives and rewards: 


Dublin-based pharmaceutical company Allergen was faced with the challenge of improving on its historic sales growth, setting a goal for itself to attain a return of $3 in value for every $1 spent on its incentive program. Keeping things interesting were the unique competitive environments faced by the products in Allergen's portfolio, combined with the significant regulations being placed on pharmaceutical companies in the U.S. and abroad.
  

8.Change Management with knowledge management:

knowledge management in organizations often is neglected. Knowledge management describes the conscious and systematic handling of the resource of knowledge and its targeted application within an organization (Annmarie-Rottweiler, Mandel, Bleacher, & Bauer, 2001). In the light of knowledge management measures we will demonstrate its implementation in organizations. We first work out a theoretical framework showing the necessary basic conditions for implementing knowledge management. Subsequently we integrate the framework into a process model that will then be illustrated by a case study. At first we will present implementation-relevant psychological aspects.
  

9.implementation of effective knowledge management:

Knowledge Management (KM) is one of the most important systems for any bio pharmaceutical company. KM is a vital connection between other management subsystems in an organization. This article focuses on the steps needed for successful implementation of KM in a bio pharmaceutical company. The KM implementation discussed here enables new possibilities of effective usage and allows exploration of valuable information existing in a company. The article also emphasizes the use of an electronic document management system (EMS) and the implementation of other such innovative information technology tools. Case studies from the bio pharmaceutical industry are used to illustrate the KM implementation methodology.



10.critical success factors of knowledge management:
 
success factors of KM process implementation in Jordan pharmaceutical industry, which aim to help in the process of using, sharing practices, creating new knowledge. Questioner was designed and sent to high and middle managers of the important pharmaceutical firms in Jordan to investigate of critical success factors in those firms, in order to improve products, services, communicate and collaborative with these firms. The result lead recommends that Jordan firms require to focusing in organization culture that supported to knowledge sharing, across and among employee/business units. Employees need a strong team culture to adaptation with knowledge mangement process. In addition, firms should compile technology environment coped with changes, challenges in the dynamic business environment to support  


11.suggestion for academic and practical inspiration:


after conducting interviews and editing the stories for this month’s Emerging Pharma Leaders section, I couldn’t help but be inspired. Our Emerging Eleven for 2017 shine a positive light for the future of pharma. As I mention in the introduction, many of this year’s alumni share commonalities, including alias Henderson willingness to grow, the ability to listen, learn from their mentors, and an enthusiasm to lead their staff and share the load. The Emerging Eleven inspired me this month to feature the staff of Pharmaceutical Executive and highlight their unique skills and qualities that make this publication and website the very best it can be. They have great ideas and deserve recognition and a big thank you!

12.Mind map of overall knowledge management and technology:
Image result for pharma company mind map of all knowledge management
 
 Image result for pharma company mind map of all knowledge management

 




 

 


 













 

 

 



 
 

Comments

Popular posts from this blog

WISDOMS